Michael Herring, 25 Year Medical Device Sales Experience, Joins HD Medical as US Vice President of Sales

Michael Herring brings his 25 years of experience in medical device sales to the company, having previously worked for 3M, Cantel Medical, Nanosonics, and TSO3.

Michael Herring plans to leverage his unique background in medical device sales management and training to further elevate the company as it continues to expand its digital health offerings.

Michael Herring will play an integral role in establishing sales channels for HD Medical’s flagship product, HD Steth.

HD Steth is the first of its kind FDA Cleared Intelligent Stethoscope with ECG and PCG in a single device. This simple to use the device with familiar stethoscope form factor and workflow enables clinicians, hospitals, and telehealth providers to capture, record, replay, and visualize heart sounds and ECG waveforms instantaneously on the HD Steth Android or Apple iOS app. The HD Steth app delivers superior ECG waveforms with the ability to detect high-frequency heart sounds indicative of murmurs.

The HD Steth provides medical professionals with access to patented algorithms and High-Definition visualization and noise-cancellation technologies that support an instantaneous diagnosis by a remote specialist, leveraging the power of AI and predictive analytics in both the HD Steth and the HD Steth app as well as in the cloud delivering connected, collaborative care.

“I’m excited to join the HD Medical team as the US VP of Sales to accelerate the domestic market adoption of HD Steth, a lifesaving intelligent stethoscope with integrated ECG,” said Michael Herring. “It’s a pleasure to represent the leading cardiac triage stethoscope innovator delivering clinicians with Instant Cardiac Insights at the Point-of-Care.”

“As our offering of digital health solutions for cardiac care continues to grow and evolve, we recognized the need for an experienced and knowledgeable team member to drive our sales team,” said Arvind Thiagarajan, founder, and CEO of HD Medical. “Mike’s background, combined with his drive and ability to ramp our sales efforts have allowed us to secure new sales representatives in several territories and progressing towards National coverage soon. His strategies will help HD Medical to continue to grow into the worldwide digital health brand that we set out to create.”

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.